Werewolf Therapeutics, Inc. (HOWL) — Operating Income
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$60.68M | +17.6% |
| 2024 | -$73.59M | -81.7% |
| 2023 | -$40.50M | +27.7% |
| 2022 | -$56.06M | -11.9% |
| 2021 | -$50.09M | -123.6% |
| 2020 | -$22.40M | — |
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$60.68M | +17.6% |
| 2024 | -$73.59M | -81.7% |
| 2023 | -$40.50M | +27.7% |
| 2022 | -$56.06M | -11.9% |
| 2021 | -$50.09M | -123.6% |
| 2020 | -$22.40M | — |